Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KROS - Keros Therapeutics, Inc.
34.8 M
LAST VALUE
27.79%
2 YEAR CAGR
85.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR